Effect of percutaneous nephrolithotomy on renal functions in children: assessment by quantitative SPECT of 99mTc-DMSA uptake by the kidneys
dc.contributor.author | Cicekbilek, Izzet | |
dc.contributor.author | Resorlu, Berkan | |
dc.contributor.author | Oguz, Ural | |
dc.contributor.author | Kara, Cengiz | |
dc.contributor.author | Unsal, Ali | |
dc.date.accessioned | 2025-01-27T20:58:00Z | |
dc.date.available | 2025-01-27T20:58:00Z | |
dc.date.issued | 2015 | |
dc.department | Çanakkale Onsekiz Mart Üniversitesi | |
dc.description.abstract | Objective: To determine the impact of percutaneous nephrolithotomy (PNL) on global and regional renal function in children. Methods: In total, 40 children (41 renal units) undergoing PNL were included in this prospective study. All patients were evaluated using quantitative single-photon emission computed tomography (QSPECT) with technetium-99 m-dimercaptosuccinic acid (Tc-99m-DMSA) examinations before and 3 months after surgery. Results: The mean age was 9.5 years (range, 3-16), and the mean stone size was 3.4 cm (range, 2-6.5). Of the cases, 39 (95%) were managed as being stone-free after a single session of PNL. After additional treatment procedures, 40 (97.5%) of the cases were managed as being stone-free. Of the 41 renal units, new focal cortical defects on Tc-99m-DMSA scans were seen in 4 (9.7%) patients. Total relative uptake in the treated kidneys increased from 42.3% to 44.1%. The mean creatinine level before PNL was 1.18 +/- 0.45 (0.8-1.6) mg/dL compared with 1.16 (0.7-1.5) mg/dL by the end of the follow-up period (not statistically significantly different, p>0.05). Conclusions: PNL in children is a safe and feasible method for the maximal clearance of stones. QSPECT of Tc-99m-DMSA confirmed that renal function is preserved or even improved after percutaneous stone removal. | |
dc.identifier.doi | 10.3109/0886022X.2015.1056063 | |
dc.identifier.endpage | 1121 | |
dc.identifier.issn | 0886-022X | |
dc.identifier.issn | 1525-6049 | |
dc.identifier.issue | 7 | |
dc.identifier.pmid | 26067745 | |
dc.identifier.scopus | 2-s2.0-84941888815 | |
dc.identifier.scopusquality | Q2 | |
dc.identifier.startpage | 1118 | |
dc.identifier.uri | https://doi.org/10.3109/0886022X.2015.1056063 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12428/26578 | |
dc.identifier.volume | 37 | |
dc.identifier.wos | WOS:000361339400008 | |
dc.identifier.wosquality | Q4 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | |
dc.publisher | Taylor & Francis Ltd | |
dc.relation.ispartof | Renal Failure | |
dc.relation.publicationcategory | info:eu-repo/semantics/openAccess | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.snmz | KA_WoS_20250125 | |
dc.subject | Percutaneous nephrolithotomy | |
dc.subject | renal function | |
dc.subject | stone disease | |
dc.subject | renal scintigraphy | |
dc.subject | renal parenchymal scar | |
dc.title | Effect of percutaneous nephrolithotomy on renal functions in children: assessment by quantitative SPECT of 99mTc-DMSA uptake by the kidneys | |
dc.type | Article |